marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Plus Therapeutics Cash Flow 2011-2024 | PSTV
Annual Cash Flow Plus Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-12.9 M | -13 M | -10.3 M | -8.43 M | -5.91 M | -12 M | -18.1 M | - | - | - | -34.6 M | -32.2 M | -35.3 M |
Depreciation & Amortization |
628 K | 619 K | 395 K | 366 K | 896 K | 2 M | 2.15 M | 1.18 M | 1.09 M | 779 K | 1.63 M | 933 K | 855 K |
Accounts Payables |
4.76 M | 8.36 M | 2.61 M | 789 K | 327 K | 721 K | 1.3 M | 1.33 M | 1.01 M | 949 K | 965 K | 1.58 M | - |
Accounts Receivables |
- | - | - | - | 1.17 M | 286 K | 145 K | 1.24 M | 1.05 M | 1.24 M | 4.15 M | 3.93 M | 2.26 M |
Total Inventories |
- | - | - | - | 107 K | 2.95 M | 3.18 M | 3.72 M | 4.3 M | 4.83 M | 3.69 M | 3.18 M | 3.32 M |
All numbers in USD currency
Quarterly Cash Flow Plus Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -4.51 M | - | - | - | -5.79 M | - | -10.7 M | - | -3.88 M | - | -7.66 M | -5.4 M | -3.01 M | - | -5.21 M | -2.91 M | -1.5 M | - | -6.94 M | -4.42 M | -3.27 M | - | -9.49 M | -6.84 M | -4.12 M | - | -13.9 M | -9.86 M | - | - | - | - | - | - | - | - | - | - | - | - | -8.96 M | - | -25.1 M | -17 M | -9.29 M | - | -23.9 M | -16 M | -7.71 M | - | -27.4 M | -19.5 M | -10.6 M |
Depreciation & Amortization |
- | - | 155 K | - | - | - | 158 K | - | 460 K | - | 147 K | - | 266 K | 179 K | 88 K | - | 273 K | 188 K | 94 K | - | 778 K | 617 K | 443 K | - | 1.46 M | 975 K | 497 K | - | 1.62 M | 1.05 M | 442 K | - | 794 K | 574 K | 291 K | - | 761 K | 510 K | 213 K | - | 525 K | 344 K | 160 K | - | 1.17 M | 660 K | 200 K | - | 712 K | 453 K | 220 K | - | 621 K | 400 K | 194 K |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | 2.61 M | - | - | - | 789 K | - | - | - | 327 K | - | - | - | 721 K | - | - | - | 1.3 M | - | - | - | 1.33 M | - | - | - | 1.01 M | - | - | - | 949 K | - | - | - | 965 K | - | - | - | 1.58 M | - | - | - | 272 K | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 951 K | 978 K | 1.17 M | 1.17 M | 1.17 M | 1.17 M | 178 K | 178 K | 178 K | 286 K | 130 K | 145 K | 145 K | 145 K | 1.24 M | 1.24 M | 1.24 M | 1.24 M | 1.05 M | 1.05 M | 1.05 M | 1.05 M | 1.24 M | 1.24 M | 1.24 M | 1.24 M | 4.15 M | 4.15 M | 4.15 M | 4.15 M | 3.93 M | 3.93 M | 3.93 M | 3.93 M | 2.26 M | 2.26 M | 2.26 M | 2.26 M |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 107 K | 107 K | 107 K | 107 K | 107 K | 107 K | 107 K | 107 K | 107 K | 107 K | 2.95 M | 107 K | 3.18 M | 3.18 M | 3.18 M | 3.72 M | 3.72 M | 3.72 M | 3.72 M | 4.3 M | 4.3 M | 4.3 M | 4.3 M | 4.83 M | 4.83 M | 4.83 M | 4.83 M | 3.69 M | 3.69 M | 3.69 M | 3.69 M | 3.18 M | 3.18 M | 3.18 M | 3.18 M | 3.32 M | 3.32 M | 3.32 M | 3.32 M |
All numbers in USD currency